Let’s discuss government’s decision to put a temporary hold on the rollout of the Astrazeneca COVID-19 vaccine. A study has shown it's only 22 percent effective against the local Covid-19 variant in mild to moderate cases. However researchers are still confident it will provide protection against severe cases. #eNCA Courtesy #DStv403
JOHANNESBURG - Clinical trials on AstraZeneca's COVID-19 vaccine have only shown a 22-percent efficiency against the variant first discovered in South Africa.
But doctors and researchers are confident it will prevent severe illness and death from COVID-19.
Government is halting the rollout of the vaccine temporarily following the results of the trial.
Research and innovation professor Mosa Moshabela at UKZN says the AstraZeneca vaccine should not be written off just yet.
Meanwhile, 183 more COVID-19 related deaths were reported in the last 24 hours, with 1,376 new cases.
